In 342 cancer cases with BRCA1/2 mutation, which was referred to as HR deficiency, a higher tumor stage was correlated with both higher HRD component scores and a higher HRD combined score, except for the comparison between stage IV and stage III and between stage IV and stage II (Figure 1A). Here, BRCA1 is linked to cancer.